SOD1 and amyotrophic lateral sclerosis: However, while some preliminary data from SOD1-mutated mice highlighted a disease progression-dependent decrease in peripheral Tregs during active phases of ALS (9), longitudinal studies assessing Tregs number in ALS patients are lacking, and interpretation of Treg variations compared to placebo in clinical trials might be challenging.